Quanterix
Quanterix Corporation is a life sciences company focused on advancing precision health through its innovative digital immunoassay platform, Simoa. This ultra-sensitive technology allows for the detection of protein biomarkers in extremely low concentrations within biological samples, such as blood and serum, which traditional immunoassay methods cannot identify. Quanterix's solutions enable rapid and accurate quantification of individual proteins and small molecules, addressing various unmet medical needs in clinical diagnostics, drug development, and life science research. By improving the ability to detect disease at earlier stages, Quanterix aims to enhance prognosis and treatment precision, ultimately contributing to better health outcomes and quality of life for individuals. The company's product offerings include a range of assay kits, instruments, and specialized services designed to meet the demands of researchers and healthcare professionals.
Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.
Emission iNC's mission is to democratize multiplex assays through affordable yet higher-performance instruments and reagents.
UmanDiagnostics specializes in providing neurofilament light (Nf-L) antibodies and ELISA kits aimed at enhancing the diagnosis and treatment of neurodegenerative diseases. The company develops biopharmaceutical products that facilitate the accurate measurement of neurofilament light in cerebrospinal fluid, enabling healthcare professionals to quickly and effectively assess various neurological conditions and traumatic brain injuries. By offering innovative diagnostic tools, UmanDiagnostics contributes to the advancement of therapeutics and diagnostics in the field of neurology, improving the ability to detect and manage neurological disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.